0001214659-22-011325.txt : 20220920
0001214659-22-011325.hdr.sgml : 20220920
20220920163015
ACCESSION NUMBER: 0001214659-22-011325
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220919
FILED AS OF DATE: 20220920
DATE AS OF CHANGE: 20220920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jackman Stephan
CENTRAL INDEX KEY: 0001864257
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40483
FILM NUMBER: 221254029
MAIL ADDRESS:
STREET 1: C/O ALZAMEND NEURO, INC.
STREET 2: 3802 SPECTRUM BOULEVARD, SUITE 112C
CITY: TAMPA
STATE: FL
ZIP: 33612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alzamend Neuro, Inc.
CENTRAL INDEX KEY: 0001677077
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811822909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 3500 LENOX RD. NE
STREET 2: SUITE 1500
CITY: ATLANTA
STATE: GA
ZIP: 30326
BUSINESS PHONE: 844-722-6333
MAIL ADDRESS:
STREET 1: 3500 LENOX RD. NE
STREET 2: SUITE 1500
CITY: ATLANTA
STATE: GA
ZIP: 30326
4
1
marketforms-57156.xml
PRIMARY DOCUMENT
X0306
4
2022-09-19
0001677077
Alzamend Neuro, Inc.
ALZN
0001864257
Jackman Stephan
3500 LENOX RD NE, SUITE 1500
ATLANTA
GA
30326
true
true
false
false
Chief Executive Officer
Common Stock
2022-09-19
4
P
false
8500
1.2252
A
8500
D
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $1.2252. The range of purchase prices on the transaction date was $1.225 to $1.23 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
/s/ Stephan Jackman
2022-09-20